Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...

A year-long clinical trial has found that Ambroxol, a cough syrup commonly sold across Europe, could potentially slow the ...

The AI tool, StateViewer, helped researchers identify a person’s dementia type in 88% of cases, according to results newly ...

A COMMON cough medicine could help protect people with Parkinson’s against dementia. Around 145,000 people in the UK have ...

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...

New research finds that diet, exercise, and stress management helped improve or stabilize brain function in early-stage ...

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...

Research study in London shows a common cough medicine as a potential treatment to slow dementia, reports CTV London’s Reta ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

About half of those diagnosed with Parkinson's develop dementia within 10 years, profoundly affecting patients, families and the health care system ...